Pfizer and 3SBio conclude licensing deal for SSGJ-707
The antibody targets programmed cell death protein 1 and vascular endothelial growth factor and was developed using 3SBio's CLF2 platform.
As part of the agreement, which was signed in May 2025, 3SBio will receive $1.25bn, along with a $100m equity investment from Pfizer.
The agreement also includes an option for Pfizer to extend its licensing rights to include exclusive development and commercialisation of SSGJ-707 in China, for which Pfizer will pay up to $150m in option payments to 3SBio.
Pfizer research and development chief scientific officer and president Chris Boshoff stated: 'We are excited to contribute our significant expertise and resources to rapidly advance the development of the SSGJ-707 programme, including novel combination strategies across a number of our major tumour areas of focus.
'This is an important candidate that combines two key targets in a promising class of medicines, complementing our antibody-drug conjugate portfolio and further demonstrating our commitment to advancing pioneering science to deliver transformative cancer medicines and new hope to people living with cancer.'
SSGJ-707 is undergoing multiple clinical trials in China for metastatic colorectal cancer, non-small cell lung cancer (NSCLC) and gynaecological tumours.
Interim Phase II data have shown positive outcomes regarding the efficacy and safety of SSGJ-707 as a single agent for patients with advanced NSCLC.
Pfizer intends to manufacture the drug substance for the antibody in Sanford in the US state of North Carolina, and the drug product in Kansas.
The clinical development plan for SSGJ-707 will involve trial centres in the US and globally, with a focus on the Phase III worldwide development plan for NSCLC as well as other solid tumours.
"Pfizer and 3SBio conclude licensing deal for SSGJ-707" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Fehler beim Abrufen der Daten
Melden Sie sich an, um Ihr Portfolio aufzurufen.
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
o9 Introduces Li Auto's Integrated Planning Capabilities
Li Auto Inc. (NASDAQ:LI) is among the 12 Best EV Charging Stocks to Buy According to Hedge Funds. o9 announced the complete implementation of its Integrated Business Planning and Supply Planning capabilities at Li Auto Inc. (NASDAQ:LI), accomplishing a significant digital transformation milestone in less than a year. The collaboration began in late 2023 and achieved its first success within three months, with the implementation of Sales and Operations Planning technology. michael-fousert-YhXlYJYlr3c-unsplash Li Auto Inc. (NASDAQ:LI), a fast-expanding electric vehicle manufacturer in China, is among the first companies in the industry to utilize o9's Digital Brain platform for integrated end-to-end planning. It is among the Best EV Stocks. The collaboration yielded eight unique solutions, including a procurement-centered supply network, automatic BOM-to-SKU conversion, and integration with Feishu for real-time communication. According to Li Auto Inc. (NASDAQ:LI)'s IT Product Director Dongxin Wan, the solutions improve the business's flexibility and decision-making throughout its supply chain. Chakri Gottemukkala, the CEO of o9, acknowledged this collaboration as a standard in the digital transformation initiatives of the AI-powered EV market. While we acknowledge the potential of LI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 minutes ago
- Yahoo
FAT Brands Inc (FAT) Q2 2025 Earnings Call Highlights: Navigating Challenges and Capitalizing ...
Release Date: July 30, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points FAT Brands Inc (NASDAQ:FAT) has been recognized on Time and Statista's best mid-sized company list for the second consecutive year. The company has a diversified global restaurant portfolio with approximately 2,300 locations across 49 states and 35 countries. FAT Brands Inc (NASDAQ:FAT) has a robust development pipeline with approximately 1,000 locations committed to open over the next 5 to 7 years. The company is seeing strong performance in its snack segment, with Great American Cookies and Marble Slab Creamery showing consistent strength. FAT Brands Inc (NASDAQ:FAT) has implemented over $5 million in annual SGNA reductions and identified further cost optimization opportunities. Negative Points Total revenues decreased by 3.4% to $146.8 million compared to the previous year's quarter. The company reported a net loss attributable to FAT Brands of $54.2 million, an increase from the previous year's net loss. General and administrative expenses increased significantly due to non-cash share-based compensation expenses. Market volatility has delayed the planned $75 to $100 million equity raise for Twin Peaks. The company is facing challenges in the QSR space, with brands like Fasoli's experiencing a tougher sales environment. Q & A Highlights Warning! GuruFocus has detected 8 Warning Signs with FAT. Q: Can you provide an update on the SEC civil action following the DOJ case dismissal, and will you recover any past legal costs from insurance? A: We are hopeful that the SEC civil case will be dismissed following the DOJ case, but we cannot comment further at this time. Regarding legal fees, which totaled $70 million over the last 3.5 years, we have filed with our insurance company and will recover the policy limits as part of the derivative case settlement. - Andy Weiderhorn, Chairman of the Board. Q: The increase in G&A costs was attributed to share-based compensation. Is this a one-time event, and should we expect G&A costs to decrease? A: Yes, the increase in G&A costs is a one-time event tied to the Twin Peaks spinoff, and costs will decrease moving forward. - Andy Weiderhorn, Chairman of the Board. Q: Can you provide a timeline for the rollout of the new manufacturing contract and its expected benefits? A: The contract is currently in production and will be fully rolled out in the next 30 to 60 days. We expect to announce further details in about 3 to 4 weeks. The contract involves different operators and will significantly benefit our cookie dough production. - Andy Weiderhorn, Chairman of the Board. Q: Are you seeing improved restaurant industry traffic similar to other companies like Cisco and Wingstop? A: The performance varies by brand category. Snack brands like cookies and ice cream are doing well, while QSR brands face challenges. However, the polished casual dining segment is improving, and we are optimistic about future consumer confidence. - Andy Weiderhorn, Chairman of the Board. Q: What is the current liquidity situation, and how are you managing financial flexibility? A: We have $130 to $150 million in retained notes for liquidity, which we can finance or sell as needed. We also have an ATM in place but have not used it much due to undervaluation concerns. We are focusing on G&A savings and accelerating the Smokey Bones portfolio conversion to improve liquidity. - Andy Weiderhorn, Chairman of the Board. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
Yahoo
13 minutes ago
- Yahoo
NIO's Firefly Brand Uses HERE Technologies to Power Smart, Connected EV Journeys
NIO Inc. (NYSE:NIO) is among the 12 Best EV Charging Stocks to Buy According to Hedge Funds. Firefly, a sub-brand of NIO Inc. (NYSE:NIO), has teamed up with HERE Technologies to incorporate innovative location services and superior map data into its intelligent electric cars. Firefly promises to enhance connected navigation, driver assistance systems, and conformity to EU Intelligent Speed Assistance rules by integrating HERE's global maps and real-time traffic updates. Furthermore, the integration makes use of HERE and Telenav 's partnership for in-car navigation. A cutting-edge electric vehicle being charged in a city street as the sun sets. Chris Chen, VP of NIO Inc. (NYSE:NIO) Global Business Development, stressed the need for HERE's global experience in satisfying international safety requirements as Firefly develops in Europe. Firefly was created for urban transportation to make high-end EV features more widely available. NIO Inc. (NYSE:NIO) displayed its explosive expansion in Q1 2025 by delivering over 42,094 vehicles, a 40.1% increase year over year. Deon Newman, SVP of HERE, pointed out the company's commitment to providing Chinese EV brands with AI-powered location technology as they expand abroad, notably in Europe. While we acknowledge the potential of NIO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
